Total raised
$24.5M
Last: Seed 2023-10
Stage
Seed
Founded
2021
Headcount
19
HQ
Haifa
Sector
Health Tech & Life Sciences
About
Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnology for the development of drug-delivery systems.
Mana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy.
The technology is powered by an integration of machine learning and nanotechnology in order to identify formulations of lipid nanoparticles drug delivery systems.
Funding history · 2 rounds · $24.5M total
2023-10
Seed
$19.5M
2021-10
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B
Highlights
Verified
Tags
pharmaceuticalsmachine-learningnanotechnologyartificial-intelligencegeneticsdrug-deliverycell-therapytherapeutics